Treatment-Resistant Depression at AACAP Annual Meeting 2026

3 sessions on treatment-resistant depression · October 26–31, 2026, Atlanta, GA. Compare treatment-resistant depression at other meetings →

Monday, October 26

13:00–15:00 · Lecture
Accelerated Theta Burst Stimulation for Treatment-Resistant Depression in ASD: From Open-Label Promise to Randomized Controlled Trial
Rana Elmaghraby
A talk within a symposium on depression in neurodiverse and gender-variant youth, covering accelerated theta burst stimulation for treatment-resistant depression in autistic youth, from open-label findings toward a randomized controlled trial.
Autism & Neurodevelopmental Disorders · Child & Adolescent · Neuromodulation (ECT, TMS)

11:30–13:00 · Lecture · Research Pipeline: New Findings on Therapeutics
Accelerated Theta Burst Stimulation for Treatment-Resistant Depression in ASD: Clinical, Cognitive, and EEG Outcomes From the RESTORE Randomized Controlled Trial
Rana Elmaghraby · Ernest Pedapati · Donald L. Gilbert · Fenil Patel
Randomized trial results on accelerated theta burst stimulation for treatment-resistant depression in autistic patients, covering clinical, cognitive and EEG outcomes.
Autism & Neurodevelopmental Disorders · Neuromodulation (ECT, TMS)

07:00–08:30 · Session
Master Clinician Paul E. Croarkin, DO, MS: Evidence-Based Interventional Psychiatry in Children and Adolescents
Paul E. Croarkin
A clinical consultation breakfast reviewing evidence, safety, regulatory and ethical issues for TMS, ECT, electrical stimulation, ketamine/esketamine and emerging psychedelic approaches in youth with treatment-resistant disorders. Uses case-based discussion on patient selection and consent/assent.
Child & Adolescent · Ketamine & Esketamine · Neuromodulation (ECT, TMS)